CURX

Curanex Pharmaceuticals Inc Common Stock CURX

CURX
Curanex Pharmaceuticals Inc Common Stock PULM
Pulmatrix, Inc. ASBP
Aspire Biopharma Holdings, Inc. PALI
Palisade Bio, Inc. LGVN
Longeveron Inc. HOTH
Hoth Therapeutics, Inc. CRIS
Curis, Inc. CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares LPTX
Leap Therapeutics, Inc. DARE
Daré Bioscience, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode CURX PULM ASBP PALI LGVN HOTH CRIS CUPR LPTX DARE
6M -90.06 % -67.41 % -68.30 % 208.21 % -59.05 % -11.11 % -52.70 % -91.82 % 318.31 % -17.49 %
YTD -90.06 % -70.39 % -99.16 % 18.28 % -70.26 % 35.05 % -75.24 % -88.47 % -63.66 % -32.61 %
1Y -90.06 % -63.82 % -99.16 % 24.29 % -71.07 % 36.84 % -66.56 % -88.47 % -60.74 % -34.24 %
3Y -90.06 % -31.57 % -99.16 % -91.85 % -98.20 % -66.12 % -88.83 % -88.47 % -72.98 % -78.47 %
5Y -90.06 % -90.48 % -99.16 % -99.94 % -99.28 % -97.48 % -99.33 % -88.47 % -94.71 % -86.20 %
10Y -90.06 % -99.71 % -99.16 % -100.00 % -99.28 % -99.51 % -99.63 % -88.47 % -98.51 % -99.50 %
Depuis le début -90.06 % -99.94 % -99.16 % -100.00 % -99.28 % -99.51 % -99.96 % -88.47 % -98.51 % -99.74 %

Dividende